Improving Culture yield rates for clostridioides difficile by using CHROMagarTM

Improving Culture yield rates for clostridioides difficile by using CHROMagarTM

Bibliographic Details
Main Authors:	T. Yi-Chun, C. Yi-Shun, H. Ya-I, J. Yue-Jiau, Y. Hsiu-Chou, Y. Pey-Luen, S. Pei-Lan, F. Hui-Min, C. Shin-Ying, Po-Ren H
Format:	Article
Language:	English
Published:	Elsevier 2020-02-01
Series:	Journal of Infection and Public Health
Online Access:	http://www.sciencedirect.com/science/article/pii/S1876034120301295

Similar Items

Development of a real-time PCR assay and comparison to CHROMagarTM STEC to screen for Shiga toxin-producing Escherichia coli in stool, Cape Town, South Africa
by: John B. Kalule, et al.
Published: (2017-12-01)

Identification of local clinical Candida isolates using CHROMagar Candida TM as a primary identification method for various Candida species.
by: Madhavan, P., et al.
Published: (2011)

Editorial: Clostridioides difficile infection
by: Guido Granata, et al.
Published: (2024-02-01)

Pathogenicity and virulence of Clostridioides difficile
by: Jessica E. Buddle, et al.
Published: (2023-12-01)

Biological characteristics associated with virulence in Clostridioides difficile ribotype 002 in Hong Kong
by: Ka Yi Kong, et al.
Published: (2020-01-01)

Diagnostic Accuracy of CHROMagar Orientation for Identification of Uropathogens
by: Nayab Ali, et al.
Published: (2023-02-01)

Metabolism the Difficile Way: The Key to the Success of the Pathogen Clostridioides difficile
by: Meina Neumann-Schaal, et al.
Published: (2019-02-01)

2’-Fucosyllactose inhibits proliferation of Clostridioides difficile ATCC 43599 in the CDi-screen, an in vitro model simulating Clostridioides difficile infection
by: Maria Wiese, et al.
Published: (2022-10-01)

Epidemiology of Clostridioides difficile in South Africa.
by: Pieter de Jager, et al.
Published: (2021-01-01)

Cutting edges in Clostridioides difficile infections
by: Ana Durovic, et al.
Published: (2021-10-01)

Characterizing the flavodoxin landscape in Clostridioides difficile
by: Daniel Troitzsch, et al.
Published: (2024-03-01)

Clostridioides difficile: A diagnostic intervention
by: Majd Alsoubani, et al.
Published: (2022-07-01)

Editorial: Microbial interactions of Clostridioides difficile
by: Shan Goh, et al.
Published: (2023-01-01)

Phage therapy for Clostridioides difficile infection
by: Kosuke Fujimoto, et al.
Published: (2022-10-01)

Trends in incidence and clinical outcomes of Clostridioides difficile infection, Hong Kong
by: Guo, Cosmos L. T., et al.
Published: (2022)

Opportunities for Nanomedicine in <i>Clostridioides difficile</i> Infection
by: Pei-Wen Wang, et al.
Published: (2021-08-01)

Intestinal Microbiota in Elderly Inpatients with Clostridioides difficile Infection
by: Vakili B, et al.
Published: (2020-08-01)

Effect of Doxycycline in Decreasing the Severity of <i>Clostridioides difficile</i> Infection in Mice
by: Bo-Yang Tsai, et al.
Published: (2022-01-01)

Genomic Epidemiology of Clostridioides difficile ST81 in Multiple Hospitals in China
by: Xia X, et al.
Published: (2024-12-01)

Gut metabolites predict Clostridioides difficile recurrence
by: Dawkins, Jennifer J., et al.
Published: (2022)

Expansion of a versatile pathogen: Clostridioides difficile
by: Tereena Lucas, et al.
Published: (2024-12-01)

Role of glycogen metabolism in Clostridioides difficile virulence
by: Md Kamrul Hasan, et al.
Published: (2024-09-01)

The role of gut fungi in Clostridioides difficile infection
by: Lamei Wang, et al.
Published: (2024-06-01)

Bacterial metabolites influence the autofluorescence of Clostridioides difficile
by: Taylor D. Ticer, et al.
Published: (2024-10-01)

Spores of Clostridioides difficile are toxin delivery vehicles
by: Carolina P. Cassona, et al.
Published: (2024-07-01)

Clostridioides difficile infection in the Asia-Pacific region
by: Deirdre A. Collins, et al.
Published: (2020-01-01)

An integrated pipeline for prediction of Clostridioides difficile infection
by: Jiang Li, et al.
Published: (2023-10-01)

Current and future approaches in Clostridioides Difficile management
by: George Sebastian Gherlan
Published: (2022-06-01)

Clostridioides difficile spore: coat assembly and formation
by: Ji Zeng, et al.
Published: (2022-12-01)

Consortium of Probiotics Attenuates Colonization of Clostridioides difficile
by: Xianping Li, et al.
Published: (2019-12-01)

Clostridioides difficile Treatment Protocol and Healthcare Burden
by: Isabel Cruz Carvalho, et al.
Published: (2022-09-01)

Fidaxomicin Use in the Pediatric Population with Clostridioides difficile
by: Oliver MB, et al.
Published: (2022-09-01)

Clostridioides difficile and neurological disorders: New perspectives
by: Manuele Biazzo, et al.
Published: (2022-09-01)

Gut metabolites predict Clostridioides difficile recurrence
by: Jennifer J. Dawkins, et al.
Published: (2022-06-01)

Clostridioides difficile infection: An emerging zoonotic disease
by: Abraham Joseph Pellissery, et al.
Published: (2022-06-01)

An intact S-layer is advantageous to Clostridioides difficile within the host
by: Michael J. Ormsby, et al.
Published: (2023-06-01)

An intact S-layer is advantageous to Clostridioides difficile within the host.
by: Michael J Ormsby, et al.
Published: (2023-06-01)

Clostridioides difficile Biology: Sporulation, Germination, and Corresponding Therapies for C. difficile Infection
by: Duolong Zhu, et al.
Published: (2018-02-01)

<i>Clostridioides difficile</i> Infection in Kidney Transplant Recipients
by: UZhe Ding, et al.
Published: (2024-02-01)

Environmental approaches to controlling Clostridioides difficile infection in healthcare settings
by: Philip C. Carling, et al.
Published: (2023-09-01)